Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers Urinary 3MT levels and prognosis were investigated in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results